Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 1.46308325
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

5.21 0.02 (0.39%)

291.73% Gain from 52W Low

153.1K

XNAS Volume

XNAS 13 Mar, 2026 10:48 AM (EDT)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Neutral

52.7 / 100

1Yr Price target upside is 162%

14 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

291.73% Gain from 52W Low

SWOT Analysis

Compass Therapeutics Inc Live Price Chart